1. 000197 THE ANTI-IDIOTYPIC MONOCLONAL ANTIBODY ACA125 IN PATIENTS WITH RECURRENT EPITHELIAL OVARIAN, FALLOPIAN TUBE OR PERITONEAL CANCER. A PHASE II TRIAL OF THE AGO-OVAR. (1st September 2005) Authors: Belau, A. K.; Kimmig, R.; Wollschlager, K.; Heilmann, V.; Harter, P.; Hilpert, F.; Sehouli, J.; Loibl, S.; Canzler, U.; Pfisterer, J. Journal: International journal of gynecological cancer Issue: Volume 15(2005)Supplement 2 Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2703 Computed tomography is more sensitive than CA 125 in detecting disease progression in patients with platinum-resistant ovarian cancer: Analysis of the AURELIA trial. (September 2015) Authors: Lindeman, K.; Kristensen, G.; Raza Mirza, M.; Davies, L.; Hilpert, F.; Romero, I.; Ayhan, A.; Burges, A.; Rubio, M.J.; Raspagliesi, F.; Huizing, M.; Creemers, G.J.; Lykka, M.; Lee, C.; Gebski, V. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 34LBA Fosaprepitant for the prevention of nausea and emesis during five weeks of chemo-radiotherapy: A multinational randomised, placebo-controlled, double-blind trial – the GAND-emesis study. (September 2015) Authors: Ruhlmann, C.H.; Christensen, T.B.; Dohn, L.H.; Paludan, M.; Rannengart, E.; Hilpert, F.; Feyer, P.; Kristensen, G.; Keefe, D.; Hansen, O.; Herrstedt, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S727 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ADAPTcycle – adjuvant dynamic marker-adjusted personalized therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate risk HR+/HER2- early breast cancer. (March 2019) Authors: Harbeck, N.; Gluz, O.; Christgen, M.; Graeser, M.; Hilpert, F.; Kreipe, H.H.; Nitz, U.; Kates, R.; Schinkoethe, T.; Kuemmel, S. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO. (October 2016) Authors: Klar, M.; Hasenburg, A.; Hasanov, M.; Hilpert, F.; Meier, W.; Pfisterer, J.; Pujade-Lauraine, E.; Herrstedt, J.; Reuss, A.; du Bois, A. Journal: European journal of cancer Issue: Volume 66(2016) Page Start: 114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗